CPT code 47380 denotes open surgical radiofrequency ablation of one or more hepatic tumors. This procedure is clinically significant as a liver-directed local therapy for tumors when an open approach is indicated, offering a targeted option for tumor control. National interest centers on appropriate use, site-of-service determination, and payer coverage policies affecting access and facility reimbursement.

Key payers commonly involved in coverage decisions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and procedural intent, typical sites of service, common payer considerations, and the types of benchmarks and policy updates that influence utilization and reimbursement. The publication outlines where to expect variation in coverage and authorization requirements across major payers and highlights coding considerations that affect claims processing.

The content provides practical billing context (service line and site of service), a summary of payer coverage landscape, and guidance on where policy changes or clinical guidelines may alter utilization. Data gaps from the provided input are noted where applicable as "Data not available in the input."